Limertinib
Limertinib (ASK120067) is an oral, potent, and selective EGFR tyrosine kinase inhibitor designed to target the T790M resistance mutation. It is a valuable research tool for investigating non-small cell lung cancer (NSCLC) in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
1934259-00-3
Product Name Alternative
ASK120067, ASK-120067, ASK 120067
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.44% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (3.66 mM) ; DMSO:40 mg/mL (73.25 mM)
Smiles
O=C (C=C) NC1=CC (NC2=NC=C (Cl) C (=N2) NC=3C=CC=4C=CC=CC4C3) =C (OC) C=C1N (C) CCN (C) C
Molecular Formula
C29H32ClN7O2
Molecular Weight
546.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A09164-1-Fluoro647 100 µg/Vial
Anti-RPS15A Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details OPCA04453-500UG 500 µg
OPCA04453-500UG - GLPE Recombinant Protein (Escherichia coli)
Sign In for Pricing
View Details 
